Nu-Med Plus Inc earned $0.00 per diluted share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Nu-Med Plus Inc has filed alongside them.
FY2025 annual
EPS (Diluted)$0.00
YoYn/m
5Y CAGRn/m
Source SEC Filings (10-K/10-Q)Latest period Q2 FY2026, ended Jun 30, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
NUMD EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Nu-Med Plus Inc earned $0.00 per diluted share in fiscal year 2025.
Nu-Med Plus Inc (NUMD) reported $0.00 per diluted share in fiscal year 2024 and $0.00 per diluted share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Across the 14 fiscal years this page covers, Nu-Med Plus Inc (NUMD) diluted earnings per share went from -$0.01 in fiscal year 2012 to $0.00 in fiscal year 2025.
Nu-Med Plus Inc (NUMD) reported $0.00 in diluted earnings per share in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Nu-Med Plus Inc (NUMD) reported on that line in every period on record.
